It was a pleasure to introduce the COMPACT clinical trial, featuring an optimized accelerated iTBS protocol for patients with treatment-resistant depression, at the Neuroscience Academy Denmark Annual Meeting 2025 in the session on TMS – Perspectives for Research and Treatment, chaired by Prof. Thomas Graven-Nielsen and Prof. John Rothwell.

Postdoc Armita Faghani Jadidi presented the overall aims and design of the study, highlighting our novel approaches. It was wonderful to receive such positive feedback afterward and to connect with both familiar colleagues and new inspiring researchers during the meeting.

Happy to showcase the exciting work we’re doing at Danish Research Centre for Magnetic Resonance (DRCMR) as part of the COMPACT trial.

We are looking forward to seeing what NAD brings next year!